E. Ellen Snow's most recent trade in Akebia Therapeutics Inc. was a trade of 224,000 Stock Option (Right to buy) done . Disclosure was reported to the exchange on Jan. 31, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Akebia Therapeutics Inc. | E. Ellen Snow | SVP, CFO and Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2024 | 224,000 | 224,000 | - | - | Stock Option (Right to buy) | |
| Akebia Therapeutics Inc. | E. Snow Ellen | SVP, CFO and Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2024 | 149,300 | 519,300 (0%) | 0% | 0 | Common Stock | |
| Akebia Therapeutics Inc. | Ellen E. Snow | SVP, CFO and Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jul 2023 | 560,000 | 560,000 | - | - | Stock Option (Right to buy) | |
| Akebia Therapeutics Inc. | Ellen E. Snow | SVP, CFO and Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jul 2023 | 370,000 | 370,000 (0%) | 0% | 0 | Common Stock |